COST-UTILITY ANALYSIS OF DONEPEZIL FOR THE TREATMENT OF ALZHEIMER'S DISEASE IN THAILAND

被引：0
|
作者：
Permsuwan, U. [1 ]
Niwatananun, W. [1 ]
Pimkrai, A. [2 ]
机构：
[1] Chiang Mai Univ, Chiang Mai 50000, Thailand
[2] Chiang Mai Neurol Hosp, Chiang Mai, Thailand
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.268
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A648 / A648
页数：1
相关论文
共 50 条
  • [1] EVOLUTION OF A COST-UTILITY MODEL OF DONEPEZIL FOR ALZHEIMER'S DISEASE
    Peters, Jaime L.
    Anderson, Rob
    Hoyle, Martin
    Hyde, Chris
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2013, 29 (02) : 147 - 154
  • [2] COST-UTILITY ANALYSIS OF CHOLINESTERASE INHIBITORS IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE
    Turongkaravee, S.
    VALUE IN HEALTH, 2010, 13 (07) : A502 - A502
  • [3] COST-UTILITY ANALYSIS OF MULTIPLE SCLEROSIS TREATMENT IN THAILAND
    Chanatittarat, Chalakorn
    Chaikledkaew, Usa
    Prayoonwiwat, Naraporn
    Siritho, Sasitorn
    Pasogpakdee, Pakamas
    Apiwattanakul, Metha
    Riewpaiboon, Arthorn
    Thavorncharoensap, Montarat
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2018, 34 (06) : 584 - 592
  • [4] A Cost-Utility Analysis of Rivastigmine Transdermal System for the Treatment of Patients with Alzheimer's Disease in Mexico
    Cruz, Samaria
    Briones, Bernardo
    Garcia-Contreras, Fernando
    NEUROLOGY, 2011, 76 (09) : A231 - A231
  • [5] Treatment costs in Hodgkin's disease: A cost-utility analysis
    Norum, J
    Angelsen, V
    Wist, E
    Olsen, JA
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (09) : 1510 - 1517
  • [6] The cost-effectiveness of donepezil and rivastigmine in the treatment of Alzheimer's disease in Thailand private hospital
    Pattanaprateep, O
    Phongchareonsuk, P
    Chaikledkaew, U
    VALUE IN HEALTH, 2005, 8 (03) : 314 - 315
  • [7] COST-UTILITY ANALYSIS OF ROPINIROLE IN PARKINSON'S DISEASE (PD) TREATMENT
    Zerda, I
    Drozdz, A.
    Brzyski, D.
    Pochopien, M.
    Gwiosda, B.
    Lisiecka, B.
    Barlog, D.
    Glogowski, C.
    Dziurda, D.
    Rys, P.
    Plisko, R.
    VALUE IN HEALTH, 2011, 14 (07) : A323 - A323
  • [8] Cost-utility analysis of empagliflozin on chronic kidney disease progression in Thailand
    Dilokthornsakul, Piyameth
    Susantitaphong, Paweena
    Satirapoj, Bancha
    Singhan, Wanchana
    Ophascharoensuk, Vuddhidej
    JOURNAL OF MEDICAL ECONOMICS, 2025, 28 (01) : 387 - 397
  • [9] Is donepezil cost-effective in the treatment of Alzheimer's disease?
    Sobolewski, M
    Kuzniar, J
    Splawinski, J
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S97 - S97
  • [10] COST-UTILITY ANALYSIS OF HERPES ZOSTER VACCINE IN THAILAND
    Taychakhoonavudh, S.
    Suranant, N.
    Issarasenee, K.
    Laoprasertsuk, C.
    Jiamton, S.
    Chanyachailert, P.
    Leeyaphan, C.
    VALUE IN HEALTH, 2016, 19 (07) : A808 - A808
12345